The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Middlebrook, Robert G
    Financial Director born in May 1958
    Individual (1 offspring)
    Officer
    2019-08-29 ~ now
    OF - Director → CIF 0
  • 2
    Kulasi, Ziaf Ahmed
    Individual (1 offspring)
    Officer
    2022-10-01 ~ now
    OF - Secretary → CIF 0
  • 3
    Carlton, Mark Beresford Lewis
    President & Chief Scientific Officer born in May 1965
    Individual (1 offspring)
    Officer
    2016-07-29 ~ now
    OF - Director → CIF 0
  • 4
    One Marina Park Drive, One Marina Park Drive, Boston, Massachussetts, United States
    Corporate (1 offspring)
    Person with significant control
    2020-12-16 ~ now
    PE - Has significant influence or control → CIF 0
Ceased 6
  • 1
    Margus, Brad
    Chief Executive born in June 1960
    Individual
    Officer
    2016-12-01 ~ 2019-08-29
    OF - Director → CIF 0
  • 2
    Gasson, Michelle Sally-ann Albertine
    Individual
    Officer
    2016-12-01 ~ 2018-01-12
    OF - Secretary → CIF 0
  • 3
    Berrigan, Sean Daniel
    Individual
    Officer
    2018-04-12 ~ 2022-10-01
    OF - Secretary → CIF 0
  • 4
    Sutcliffe, James Holden
    Finance Director born in February 1967
    Individual
    Officer
    2016-07-29 ~ 2016-12-01
    OF - Director → CIF 0
  • 5
    PARADIGM THERAPEUTICS LIMITED - 2007-03-30
    418 Cambridge Science Park, Milton Road, Cambridge, United Kingdom
    Active Corporate (4 parents)
    Person with significant control
    2016-07-29 ~ 2016-11-30
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Has significant influence or control → CIF 0
  • 6
    Suite 1410, One Marina Park Drive, Boston, Ma, United States
    Corporate
    Person with significant control
    2016-12-01 ~ 2020-12-16
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors as a member of a firm → CIF 0
    PE - Has significant influence or control as a member of a firm → CIF 0
parent relation
Company in focus

CEREVANCE, LTD

Previous name
TAKEDA CAMBRIDGE NEUROSCIENCE LIMITED - 2016-12-06
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
442023-01-01 ~ 2023-12-31
402022-01-01 ~ 2022-12-31
Turnover/Revenue
17,660 GBP2023-01-01 ~ 2023-12-31
14,885 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
-18,310 GBP2023-01-01 ~ 2023-12-31
-15,301 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
533 GBP2023-01-01 ~ 2023-12-31
473 GBP2022-01-01 ~ 2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
5 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
538 GBP2023-01-01 ~ 2023-12-31
473 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-67 GBP2023-01-01 ~ 2023-12-31
417 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment
691 GBP2023-12-31
638 GBP2022-12-31
Fixed Assets
691 GBP2023-12-31
638 GBP2022-12-31
Debtors
Current
4,021 GBP2023-12-31
3,398 GBP2022-12-31
Cash at bank and in hand
2,151 GBP2023-12-31
3,049 GBP2022-12-31
Current Assets
6,172 GBP2023-12-31
6,447 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-2,148 GBP2023-12-31
-2,786 GBP2022-12-31
Net Current Assets/Liabilities
4,024 GBP2023-12-31
3,661 GBP2022-12-31
Net Assets/Liabilities
4,567 GBP2023-12-31
4,299 GBP2022-12-31
Equity
Called up share capital
1,000 GBP2023-12-31
1,000 GBP2022-12-31
1,000 GBP2022-01-01
Other miscellaneous reserve
1,986 GBP2023-12-31
1,651 GBP2022-12-31
1,342 GBP2022-01-01
Retained earnings (accumulated losses)
1,581 GBP2023-12-31
1,648 GBP2022-12-31
1,231 GBP2022-01-01
Equity
4,567 GBP2023-12-31
4,299 GBP2022-12-31
3,573 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-67 GBP2023-01-01 ~ 2023-12-31
417 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
402 GBP2023-01-01 ~ 2023-12-31
-85 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
126 GBP2023-01-01 ~ 2023-12-31
90 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,252 GBP2023-12-31
1,952 GBP2022-12-31
Computers
130 GBP2023-12-31
129 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
2,457 GBP2023-12-31
2,156 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
1,359 GBP2022-12-31
Computers
84 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
1,518 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
222 GBP2023-01-01 ~ 2023-12-31
Computers, Owned/Freehold
26 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
248 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
1,581 GBP2023-12-31
Computers
110 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,766 GBP2023-12-31
Property, Plant & Equipment
Plant and equipment
671 GBP2023-12-31
593 GBP2022-12-31
Computers
20 GBP2023-12-31
45 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
2,098 GBP2023-12-31
78 GBP2022-12-31
Other Debtors
Current
1,019 GBP2023-12-31
1,462 GBP2022-12-31
Prepayments/Accrued Income
Current
742 GBP2023-12-31
1,444 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
162 GBP2023-12-31
160 GBP2022-12-31
Debtors - Deferred Tax Asset
Current
254 GBP2022-12-31
Trade Creditors/Trade Payables
Current
1,520 GBP2023-12-31
2,094 GBP2022-12-31
Taxation/Social Security Payable
Current
329 GBP2023-12-31
91 GBP2022-12-31
Other Creditors
Current
30 GBP2023-12-31
3 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
269 GBP2023-12-31
598 GBP2022-12-31
Creditors
Current
2,148 GBP2023-12-31
2,786 GBP2022-12-31
Net Deferred Tax Liability/Asset
-148 GBP2023-12-31
254 GBP2022-12-31
169 GBP2022-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-402 GBP2023-01-01 ~ 2023-12-31
85 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
25 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000,000 shares2023-12-31
1,000,000 shares2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
531 GBP2023-12-31
531 GBP2022-12-31
Between one and five year
2,122 GBP2023-12-31
619 GBP2022-12-31
More than five year
1,282 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
3,935 GBP2023-12-31
1,150 GBP2022-12-31
  • CEREVANCE, LTD
    Info
    TAKEDA CAMBRIDGE NEUROSCIENCE LIMITED - 2016-12-06
    Registered number 10304008
    418 Cambridge Science Park Milton Road, Cambridge CB4 0PZ
    Private Limited Company incorporated on 2016-07-29 (8 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.